Literature DB >> 23128246

Changing trends in well differentiated thyroid carcinoma over eight decades.

Iain J Nixon1, Ian Ganly, Snehal G Patel, Frank L Palmer, Monica M Whitcher, Rony Ghossein, R Michael Tuttle, Ashok R Shaha, Jatin P Shah.   

Abstract

INTRODUCTION: The incidence of well differentiated thyroid cancer (WDTC) is rising in the USA. The objective of this study is to present the changes in incidence, presentation, management and outcomes of WDTC within our institution over the past 8 decades.
METHODS: 2797 patients managed between 1932 and 2005 at Memorial Sloan Kettering Cancer Center were identified from our institutional database.
RESULTS: There has been an increase in the number of patients managed per decade. Although the median age was 45 years, patients managed post-1985 were more likely to be over 45 years (53% versus 44%, p < 0.001). The percentage of women increased from 68% to 72% (p = 0.026), and the percentage of papillary carcinomas also increased, from 78% to 92%, p < 0.001. An increase in early stage tumors was observed with pT1 lesions increasing from 19% to 48%. Patients in the latter cohort were less likely to have thyroid lobectomy (29% versus 72%, p < 0.001). There was a significant change in the use of RRA, with 8% of the early versus 44% of the latter group receiving post-operative RRA (p < 0.001). Since the introduction of risk group stratification disease specific survival (DSS) has not changed significantly. With a median follow up of 90 months, 10 year DSS rates were below 90% in the cohort managed prior to the 1970s, which rose to >95% thereafter (p < 0.001).
CONCLUSIONS: Older patients with earlier stage disease present an increasing workload for surgical oncologists. Excellent outcomes remain unchanged despite increasingly aggressive surgical and medical management.
Copyright © 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23128246     DOI: 10.1016/j.ijsu.2012.10.005

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  16 in total

1.  Quantification of lymph nodes in the central compartment of the neck: a cadaveric study.

Authors:  Enyinnaya Ofo; Selvam Thavaraj; Daron Cope; James Barr; Karan Kapoor; Jean-Pierre Jeannon; Richard Oakley; Claire Lock; Edward Odell; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-20       Impact factor: 2.503

2.  In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF V600E mutation.

Authors:  Almira Nasirden; Tsuyoshi Saito; Yuki Fukumura; Kieko Hara; Keisuke Akaike; Aiko Kurisaki-Arakawa; Miki Asahina; Atsushi Yamashita; Ran Tomomasa; Takuo Hayashi; Atsushi Arakawa; Takashi Yao
Journal:  Virchows Arch       Date:  2016-10-07       Impact factor: 4.064

3.  Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection.

Authors:  I J Nixon; L Y Wang; I Ganly; S G Patel; L G Morris; J C Migliacci; R M Tuttle; J P Shah; A R Shaha
Journal:  Br J Surg       Date:  2015-10-29       Impact factor: 6.939

Review 4.  Management of Invasive Differentiated Thyroid Cancer.

Authors:  Iain J Nixon; Ricard Simo; Kate Newbold; Alessandra Rinaldo; Carlos Suarez; Luiz P Kowalski; Carl Silver; Jatin P Shah; Alfio Ferlito
Journal:  Thyroid       Date:  2016-08-23       Impact factor: 6.568

5.  Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936-2015).

Authors:  Ian D Hay; Tammi R Johnson; Suneetha Kaggal; Megan S Reinalda; Nicole M Iniguez-Ariza; Clive S Grant; Siobhan T Pittock; Geoffrey B Thompson
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

6.  Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis.

Authors:  Donald S A McLeod; Jacqueline Jonklaas; James D Brierley; Kenneth B Ain; David S Cooper; Henry G Fein; Bryan R Haugen; Paul W Ladenson; James Magner; Douglas S Ross; Monica C Skarulis; David L Steward; Mingzhao Xing; Danielle R Litofsky; Harry R Maxon; Steven I Sherman
Journal:  Thyroid       Date:  2015-08-24       Impact factor: 6.568

7.  Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates.

Authors:  Allen S Ho; Louise Davies; Iain J Nixon; Frank L Palmer; Laura Y Wang; Snehal G Patel; Ian Ganly; Richard J Wong; R Michael Tuttle; Luc G T Morris
Journal:  Cancer       Date:  2015-02-24       Impact factor: 6.860

8.  Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer.

Authors:  Iain J Nixon; Deborah Kuk; Volkert Wreesmann; Luc Morris; Frank L Palmer; Ian Ganly; Snehal G Patel; Bhuvanesh Singh; R Michael Tuttle; Ashok R Shaha; Mithat Gönen; Jatin P Shah
Journal:  Ann Surg Oncol       Date:  2015-07-28       Impact factor: 5.344

9.  PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma.

Authors:  S Beg; A K Siraj; Z Jehan; S Prabakaran; S S Al-Sobhi; M Al-Dawish; F Al-Dayel; K S Al-Kuraya
Journal:  Br J Cancer       Date:  2015-05-19       Impact factor: 7.640

10.  A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.

Authors:  Angela Chou; Sheila Fraser; Christopher W Toon; Adele Clarkson; Loretta Sioson; Mahtab Farzin; Carmen Cussigh; Ahmad Aniss; Christine O'Neill; Nicole Watson; Roderick J Clifton-Bligh; Diana L Learoyd; Bruce G Robinson; Christina I Selinger; Leigh W Delbridge; Stanley B Sidhu; Sandra A O'Toole; Mark Sywak; Anthony J Gill
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.